Enrollment of BCG naïve subjects (QUILT-2.005) receiving BCG alone versus BCG plus ANKTIVA exceeding expectations 85% enrolled with anticipated completion in Q2 2026 with BLA filing to U.S. Food and ...
Pathologic response and safety of neoadjuvant pembrolizumab with or without entinostat in muscle-invasive urothelial cancer (MIUC). Subsequent line of treatment for BCG unresponsive HR NMIBC patients ...
Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results